The U.S. government wants you to tell them what you think about weed, as the United Nations World Health Organization is set to launch a review of weed’s current classification.
The FDA is collecting public comments to find out the country’s position on the issue of cannabis before it submits comments to the UN. The group is specifically asking interested parties for input on marijuana abuse potential, medical usefulness, its actual abuse, trafficking, and the impact of Schedule 1 on its availability for medical use.
Since cannabis is considered a Schedule 1 drug, it’s not permitted to be formally prescribed to a patient and research on its effect is restricted.
W.H.O.’s Expert Committee on Drug Dependence will meet in June to discuss the classification of marijuana and will make suggestions to the UN secretary general about conducting a more in-depth analysis. Depending on the findings of that analysis, cannabis could be rescheduled on an international level, which would then provide momentum to change cannabis laws around the U.S. and worldwide. This could entail a huge win for those who are in favor of federal medical weed legalization, but are unable to even consider it because of current legislation.